According to a Caiwen report on September 18, Aipusiwei, China's first AI-assisted innovative drug, has been approved for market. It took only three and a half years from discovery to completion of clinical trials. AI shortened the drug discovery cycle by about 60% and reduced costs by 80% to 90%, becoming the core catalyst behind the rise of the biotech sector.